The compare table
Not a robo.Not a newsletter.
Foliox is a signal publisher — a category most people don’t know exists. We don’t manage your money. We don’t tell you what to buy. We publish what the models see and trust you to dress yourself.
| What you’re comparing | Foliox | Robo-advisor | Newsletter |
|---|---|---|---|
| What we are | Signal publisher | Portfolio manager | Opinion column |
| Do we trade your money? | No | Yes — managed | No |
| Do we custody? | No | Yes | No |
| Do we tell you what to buy? | No — model output only | Yes — auto-allocated | Yes — opinion picks |
| Style | Systematic, rules-based | Passive (set-and-forget) | Discretionary |
| Markets covered | 5 equity + 1 FI strategy | Limited regional ETFs | Usually US-only |
| Defensive mechanic | Yes — daily regime check | None — rides drawdowns | Discussed, not built in |
| Methodology shown | Every rule, every threshold | High-level algo described | Author’s judgement |
| Backtest evidence | 18 years + walk-forward | Index history | Cherry-pickable |
| Time you spend / week | ~10 minutes | Zero (after setup) | ~60–90 minutes |
| Cost | Free during preview | 0.25–0.5% AUM | $10–50/month |
Comparisons are generalized. Specific robo-advisors and newsletters vary by product. Foliox is currently in research preview — no AUM, no subscription, no card required.
Who it’s for
Three kinds of investor.
You manage your own portfolio.
You want a disciplined second opinion — model output as input alongside your own judgement.
You’re learning the markets.
You read the dashboard. You read the methodology. You watch for a year before changing anything.
You like rules-based thinking.
You want to see how a systematic strategy actually behaves — across regimes, across countries, across two decades.